next gen glp 1 GLP-1-based therapies for diabetes, obesity and beyond GLP-1 Pipeline Snapshot: Next-Gen Therapies

Early signs of mild dehydration include: Thirst and dry mouth Dark yellow or amber-colored urine healthy hydration typically produces pale yellow urine Decreased urination frequency or volume Fatigue and reduced energy levels often attributed to medication but may reflect dehydration Headaches particularly if new or worsening since starting therapy Dry skin and lips More concerning signs of moderate dehydration warrant prompt medical attention: Dizziness or lightheadedness , especially when standing (orthostatic symptoms) Rapid heartbeat or palpitations Confusion or difficulty concentrating Dry mucous membranes (mouth, eyes) Severe constipation unresponsive to usual measures Muscle cramps or weakness Patients with diabetes should be particularly vigilant, as dehydration can affect blood glucose readings and may contribute to hyperglycemic hyperosmolar state (HHS) in type 2 diabetes

They want guidance, consistency and a provider that understands the emotional weight of the journey, not just the physical one

Others may not see much scale change yet, which is entirely normal

GNC has officially become the world's first major retailer to establish an entire section dedicated to assisting GLP-1 users in managing the common side effects and challenges associated with treatment

Whats wrong with the 25% benchmark

The hormonal background of hair loss in non-scarring alopecias